American Well Corporation reported financial results for the second quarter ended June 30, 2026. Total revenue reached $52.0 million, with subscription revenue at $25.7 million and Amwell Medical Group visit revenue at $24.4 million. The company posted a net loss of $9.6 million and an adjusted EBITDA loss of $1.2 million. Management raised the low end of its full-year 2026 revenue guidance to $200–$205 million from $195–$205 million and improved the adjusted EBITDA outlook to a range of ($9) million to ($7) million. The company reiterated its objective to achieve positive cash flow from operations in the fourth quarter of 2026. American Well Corporation operates in the healthcare technology industry, providing a SaaS-based telehealth platform.

American Well Corporation dismissed PricewaterhouseCoopers LLP as its independent registered public accounting firm on July 14, 2026, and appointed BDO USA, P.C. as its new auditor. The company reported that there were no disagreements or reportable events with the former auditor regarding accounting principles, financial statement disclosure, or auditing scope. American Well Corporation operates in the telehealth industry and provides healthcare technology solutions.

American Well Corporation rebalanced its Board of Directors by reappointing Stephen Schlegel as a Class III director for a term expiring in 2029. This administrative reclassification was necessary to restore the three board classes to approximately equal size to comply with NYSE listing standards. American Well Corporation is a healthcare technology company providing telehealth services.